Watson CEO OK'd To Quiz FTC In Subpoena Dustup

Law360, New York (July 14, 2010, 7:25 PM EDT) -- Watson Pharmaceuticals Inc. CEO Paul M. Bisaro has won a bid to conduct discovery into whether the Federal Trade Commission shared confidential information with a rival of the generic-drug maker in an effort to force Bisaro to testify in a competition probe triggered by a patent case settlement over the narcolepsy treatment Provigil.

Such discovery is rarely granted, but Bisaro made a colorable claim that the FTC may have exceeded its authority by pressuring Watson to enter into a deal with rival Apotex Inc., according to...
To view the full article, register now.